Novo Nordisk A/S (NYSE:NVO)’s Basic Consolidated EPS Came In At $1.8013

0

The annual basic consolidated EPS for Novo Nordisk A/S (NYSE:NVO) posted annual basic consolidated EPS of $1.8013 for the year period ended2014-12-31. But basic consolidated EPS for the quarter period ended 2014-12-31 came in at $1.8013.

What About EPS from continuing operations

Novo Nordisk A/S (NYSE:NVO)’s EPS from continuing operations for the annual period ended 2014-12-31 came in at 1.8013. On quarterly basis, EPS from continuing operations stood at $1.8013 for the three-month period ended 2014-12-31.

EPS contribution from parent

Novo Nordisk A/S (NYSE:NVO) received of $1.8013 EPS boost from the parent company for the annual period ended 2014-12-31. For the quarter period ended 2014-12-31, the company received EPS boost of $1.8013 from its parent company.

What About Basic net EPS

The company’s basic net EPS for the annual period ended 2014-12-31 was$1.8008, but for the quarter period ended 2014-12-31 the basic net EPS was $1.8008.

What About Consolidated Diluted EPS?

Novo Nordisk A/S (NYSE:NVO) posted consolidated diluted EPS of $1.7951 for the annual period ended 2014-12-31. On the other hand, consolidated diluted EPS for the quarterly period ended 2014-12-31 stood at $1.7951.

Basic diluted EPS

The company’s diluted EPS from continuing operation stood at $1.7951 for the annual period ended 2014-12-31. On quarter basis, diluted EPS from continuing operations was $1.7951 for the three-month period ended 2014-12-31.

Net diluted EPS

Novo Nordisk A/S (NYSE:NVO) posted net diluted EPS of $1.7955for the annual period ended 2014-12-31. On the other hand, it posted net diluted EPS of $1.7955 for thequarterly period ended 2014-12-31.

What portion of diluted EPS came from parent?

For the annual period ended 2014-12-31, the parent company of Novo Nordisk A/S (NYSE:NVO) contributed diluted EPS of $1.7951. The diluted EPS contribution from the parent for the quarter ended 2014-12-31 stood at $1.7951.

The company’s net basic EPS for the annual period ended 2014-12-31 was $2.02 while for the quarter period ended 2014-12-31 it was $2.02.

Novo Nordisk A/S (NYSE:NVO) had average basic shares outstanding of 2570.796 for the annual period ended 2014-12-31 and 2570.796 for the quarter period ended 2014-12-31.The number of diluted shares outstanding was 2570.796 for the annual period ended 2014-12-31 and 2570.796 for the quarter ended 2014-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 14 times, 1 visits today)